Krystal Biotech (KRYS) Research & Development (2021 - 2025)
Historic Research & Development for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $14.6 million.
- Krystal Biotech's Research & Development rose 794.11% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.8 million, marking a year-over-year increase of 1040.22%. This contributed to the annual value of $53.6 million for FY2024, which is 1538.2% up from last year.
- Latest data reveals that Krystal Biotech reported Research & Development of $14.6 million as of Q3 2025, which was up 794.11% from $14.4 million recorded in Q2 2025.
- Krystal Biotech's 5-year Research & Development high stood at $15.6 million for Q2 2024, and its period low was $6.1 million during Q3 2021.
- Its 5-year average for Research & Development is $11.2 million, with a median of $11.4 million in 2023.
- In the last 5 years, Krystal Biotech's Research & Development surged by 8940.79% in 2022 and then plummeted by 1083.17% in 2024.
- Over the past 5 years, Krystal Biotech's Research & Development (Quarter) stood at $9.0 million in 2021, then increased by 19.23% to $10.7 million in 2022, then rose by 5.86% to $11.4 million in 2023, then rose by 18.92% to $13.5 million in 2024, then rose by 7.87% to $14.6 million in 2025.
- Its Research & Development was $14.6 million in Q3 2025, compared to $14.4 million in Q2 2025 and $14.3 million in Q1 2025.